Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Applying to Kaiser Permanente-Capitol Hill Medical Center · Washington D.C., District of Columbia
Answer a few short questions to share with the research team.